DelveInsight's "TRYVIO/JERAYGO Market Size, Forecast, and Market Insight Report" highlights the details around TRYVIO/JERAYGO ...

The Food and Drug Administration is suspending a quality control program for its food testing laboratories as a result of ...

Bristol Myers Squibb's BMY.N drug to treat a type of heart disease did not significantly improve functional capacity and ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

Color additives have faced increased scrutiny since the FDA banned Red Dye No. 3, citing concerns over its links to cancer.

Roswell Park Comprehensive Cancer Center is at the forefront of a new approach to cancer treatment, called CAR T-cell therapy.

Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused on launching ...

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

Mesoblast (MESO) announced that it has continued to expand coverage for Ryoncil, the first mesenchymal stromal cell ...

Acquisition of Theravia from Mérieux Equity Partners represents meaningful step forward in Norgine's strategy for sustainable ...

The agency and Novo Nordisk, which makes Ozempic, said Monday that they had learned about "several hundred units" of the drug ...